An investor, who purchased shares of Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR), filed a lawsuit over alleged violations of Federal Securities Laws by Eiger BioPharmaceuticals, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Eiger BioPharmaceuticals,Lawsuit filed for Investors in shares of Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) over alleged Securities Laws Violations | openPR.com - New Public Relations: Business, Economy, Finances, Banking & Insurance
An investor, who purchased shares of Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR), filed a lawsuit over alleged violations of Federal Securities Laws by Eiger BioPharmaceuticals, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Eiger BioPharmaceuticals,